Skip to content
ppharmaranks
Menu

KEPPRA vs LEVETIRACETAM

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Rating

70/100
66/100

Pharmacy pays

~$2.34 /30
~$2.34 /30

Type

RX
RX

Active ingredient

LEVETIRACETAM
LEVETIRACETAM

Manufacturer

Dosage forms

Injectable, Solution, Tablet
Injectable, Solution, Tablet, Tablet, extended release

Drug class

Boxed warning

None
None

Half-life

about 7 hours (the label states 7 ± 1 hour in adults)
about 7 hours (the label states 7 ± 1 hour in adults)

Treats

Partial Epilepsies, Tonic-Clonic Epilepsy, Juvenile Myoclonic Epilepsy
Partial Epilepsies, Tonic-Clonic Epilepsy, Juvenile Myoclonic Epilepsy

Frequently asked questions

Which is better-rated, Keppra or Levetiracetam?

By our independent rating, Keppra scores higher — 3.5 vs 3.3 out of 5 for Levetiracetam. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Keppra or Levetiracetam?

Pharmacies pay about the same to acquire either one — roughly $2.34 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Keppra and Levetiracetam?

Both Keppra and Levetiracetam share the active ingredient Levetiracetam.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.